Monash IVF Group Statistics
Total Valuation
MNIVF has a market cap or net worth of 188.38 million. The enterprise value is 289.99 million.
| Market Cap | 188.38M |
| Enterprise Value | 289.99M |
Important Dates
The next estimated earnings date is Friday, August 22, 2025.
| Earnings Date | Aug 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 389.63M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.69% |
| Shares Change (QoQ) | +0.90% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 339.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.67 |
| PS Ratio | 1.13 |
| PB Ratio | 1.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 23.28 |
| P/OCF Ratio | 10.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.80, with an EV/FCF ratio of 35.83.
| EV / Earnings | -204.80 |
| EV / Sales | 1.66 |
| EV / EBITDA | 6.80 |
| EV / EBIT | 9.30 |
| EV / FCF | 35.83 |
Financial Position
The company has a current ratio of 0.61, with a Debt / Equity ratio of 0.63.
| Current Ratio | 0.61 |
| Quick Ratio | 0.51 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 2.43 |
| Debt / FCF | 12.19 |
| Interest Coverage | 7.85 |
Financial Efficiency
Return on equity (ROE) is -0.57% and return on invested capital (ROIC) is 7.36%.
| Return on Equity (ROE) | -0.57% |
| Return on Assets (ROA) | 6.27% |
| Return on Invested Capital (ROIC) | 7.36% |
| Return on Capital Employed (ROCE) | 11.53% |
| Revenue Per Employee | 167,464 |
| Profits Per Employee | -1,420 |
| Employee Count | 997 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 23.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.85 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 27,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MNIVF had revenue of 166.96 million and -1.42 million in losses. Loss per share was -0.00.
| Revenue | 166.96M |
| Gross Profit | 55.51M |
| Operating Income | 29.72M |
| Pretax Income | -2.41M |
| Net Income | -1.42M |
| EBITDA | 34.65M |
| EBIT | 29.72M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 4.64 million in cash and 98.64 million in debt, giving a net cash position of -93.99 million.
| Cash & Cash Equivalents | 4.64M |
| Total Debt | 98.64M |
| Net Cash | -93.99M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 157.33M |
| Book Value Per Share | 0.40 |
| Working Capital | -22.15M |
Cash Flow
In the last 12 months, operating cash flow was 18.23 million and capital expenditures -10.14 million, giving a free cash flow of 8.09 million.
| Operating Cash Flow | 18.23M |
| Capital Expenditures | -10.14M |
| Free Cash Flow | 8.09M |
| FCF Per Share | n/a |
Margins
Gross margin is 33.25%, with operating and profit margins of 17.80% and -0.85%.
| Gross Margin | 33.25% |
| Operating Margin | 17.80% |
| Pretax Margin | -1.44% |
| Profit Margin | -0.85% |
| EBITDA Margin | 20.76% |
| EBIT Margin | 17.80% |
| FCF Margin | 4.85% |
Dividends & Yields
MNIVF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.69% |
| Shareholder Yield | n/a |
| Earnings Yield | -0.75% |
| FCF Yield | 4.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MNIVF has an Altman Z-Score of 1.67. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.67 |
| Piotroski F-Score | n/a |